PBI46 Cost-Effectiveness of Treatment Sequences Initiating with Risankizumab for the Treatment of Moderate to Severe Psoriasis in Portugal
Abstract
Authors
C. Carvalho M. Batista P. Ferreira M. Henrique S. Magina M.J. Paiva Lopes M. Placido T. Torres S. Vargas J. Canilho